Drug Discovery Outsourcing Market
Drug Discovery Outsourcing Market: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033A recent market study published by FMI on Drug Discovery Outsourcing offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Workflow:
- Target Identification & Screening
- Target Validation & Functional Informatics
- Lead Identification & Candidate Optimization
- Preclinical Development
- Other Associated Workflow
- Respiratory system
- Pain and Anesthesia
- Oncology
- Ophthalmology
- Hematology
- Cardiovascular
- Endocrine
- Gastrointestinal
- Immunomodulation
- Anti-infective
- Central Nervous System
- Dermatology
- Genitourinary System
- Small Molecules
- Large Molecules (Biopharmaceuticals)
- Chemistry Services
- Biology Services
- Pharmaceutical & Biotechnology companies
- Academic Institutes
- Others
- North America
- Europe
- Japan
- Asia Pacific Excluding Japan
- Latin America
- MEA
Executive Summary
The executive summary of the Drug Discovery Outsourcing Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Drug Discovery Outsourcing Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Drug Discovery Outsourcing Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Workflow processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Drug Discovery Outsourcing Market Demand Analysis 2018-2022 and Forecast, 2023-2033
The chapter include historical market value (US$ 3.50 billion) analysis (2018-2022) and current and future market value (US$ 3.75 billion) and volume (7.2%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Drug Discovery Outsourcing Market - Pricing Analysis
Based on By Workflow, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Workflow
Based on By Workflow, Drug Discovery Outsourcing Market is segmented into Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Workflow.
Chapter 06 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Therapeutics Area
Based on By Therapeutics Area, Drug Discovery Outsourcing Market is segmented into Respiratory system, Pain and Anesthesia, Oncology, Ophthalmology, Hematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-infective, Central Nervous System, Dermatology, Genitourinary System. This section also offers market attractiveness analysis based on By Therapeutics Area. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Therapeutics Area.
Chapter 07 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Based on By Drug Type, Drug Discovery Outsourcing Market is segmented into Small Molecules, Large Molecules (Biopharmaceuticals). This section also offers market attractiveness analysis based on By Drug Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drug Type.
Chapter 08 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Service Type
Based on By Service Type, Drug Discovery Outsourcing Market is segmented into Chemistry Services, Biology Services. This section also offers market attractiveness analysis based on By Service Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Service Type.
Chapter 09 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By End-user
Based on By End-user, Drug Discovery Outsourcing Market is segmented into Pharmaceutical & Biotechnology companies, Academic Institutes, Others. This section also offers market attractiveness analysis based on By End-user. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End-user.
Chapter 10 - Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Regions
Based on By Regions, Drug Discovery Outsourcing Market is segmented into North America, Latin America, Europe, Japan, Asia Pacific Excluding Japan and MEA. This section also offers market attractiveness analysis based on By Regions. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Regions.
Chapter 11 - North America Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 12 - Latin America Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the Latin America region.
Chapter 13 - Europe Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market.
Chapter 14 - East Asia Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market.
Chapter 15 - South Asia Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market.
Chapter 16 - Middle East and Africa Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market.
Chapter 17 - Key Countries Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033
This chapter offers insights into how the Drug Discovery Outsourcing Market is expected to grow in major countries globally.
Chapter 18 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 19 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Workflow portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Albany Molecular Research Inc., EVOTEC, Laboratory Corporation of America Holdings, GenScript, Pharmaceutical Product Development, LLC, Charles River, WuXi AppTec, Merck & Co., Inc., Thermo Fisher Scientific Inc., Dalton Pharma Services, Oncodesign, Jubilant Biosys, DiscoverX Corp., QIAGEN, Eurofins SE, Syngene International Limited, Dr. Reddy Laboratories Ltd., Pharmaron Beijing Co., Ltd., TCG Lifesciences Pvt Ltd., Domainex Ltd.
Chapter 20 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.
Chapter 21 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Drug Discovery Outsourcing Market.
- 1. Executive Summary | Drug Discovery Outsourcing Market
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter’s Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
- 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
- 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Workflow
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Million) Analysis By Workflow, 2018 to 2022
- 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Workflow, 2023 to 2033
- 5.3.1. Target Identification & Screening
- 5.3.2. Target Validation & Functional Informatics
- 5.3.3. Lead Identification & Candidate Optimization
- 5.3.4. Preclinical Development
- 5.3.5. Other Associated Workflow
- 5.4. Y-o-Y Growth Trend Analysis By Workflow, 2018 to 2022
- 5.5. Absolute $ Opportunity Analysis By Workflow, 2023 to 2033
- 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapeutics Area
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Million) Analysis By Therapeutics Area, 2018 to 2022
- 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapeutics Area, 2023 to 2033
- 6.3.1. Respiratory system
- 6.3.2. Pain and Anaesthesia
- 6.3.3. Oncology
- 6.3.4. Ophthalmology
- 6.3.5. Haematology
- 6.3.6. Cardiovascular
- 6.3.7. Endocrine
- 6.3.8. Gastrointestinal
- 6.3.9. Immunomodulation
- 6.3.10. Dermatology
- 6.3.11. Central Nervous System
- 6.3.12. Genitourinary System
- 6.4. Y-o-Y Growth Trend Analysis By Therapeutics Area, 2018 to 2022
- 6.5. Absolute $ Opportunity Analysis By Therapeutics Area, 2023 to 2033
- 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Type
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Million) Analysis By Drug Type, 2018 to 2022
- 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drug Type, 2023 to 2033
- 7.3.1. Small Molecules
- 7.3.2. Large Molecules
- 7.4. Y-o-Y Growth Trend Analysis By Drug Type, 2018 to 2022
- 7.5. Absolute $ Opportunity Analysis By Drug Type, 2023 to 2033
- 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
- 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
- 8.3.1. Pharmaceutical and Biotechnology companies
- 8.3.2. Academic Institutes
- 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
- 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
- 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
- 9.1. Introduction
- 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
- 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
- 9.3.1. North America
- 9.3.2. Latin America
- 9.3.3. Europe
- 9.3.4. South Asia
- 9.3.5. East Asia
- 9.3.6. Oceania
- 9.3.7. MEA
- 9.4. Market Attractiveness Analysis By Region
- 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 10.2.1. By Country
- 10.2.1.1. USA
- 10.2.1.2. Canada
- 10.2.2. By Workflow
- 10.2.3. By Therapeutics Area
- 10.2.4. By Drug Type
- 10.2.5. By End User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Workflow
- 10.3.3. By Therapeutics Area
- 10.3.4. By Drug Type
- 10.3.5. By End User
- 10.4. Key Takeaways
- 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 11.2.1. By Country
- 11.2.1.1. Brazil
- 11.2.1.2. Mexico
- 11.2.1.3. Rest of Latin America
- 11.2.2. By Workflow
- 11.2.3. By Therapeutics Area
- 11.2.4. By Drug Type
- 11.2.5. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Workflow
- 11.3.3. By Therapeutics Area
- 11.3.4. By Drug Type
- 11.3.5. By End User
- 11.4. Key Takeaways
- 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 12.2.1. By Country
- 12.2.1.1. Germany
- 12.2.1.2. United kingdom
- 12.2.1.3. France
- 12.2.1.4. Spain
- 12.2.1.5. Italy
- 12.2.1.6. Rest of Europe
- 12.2.2. By Workflow
- 12.2.3. By Therapeutics Area
- 12.2.4. By Drug Type
- 12.2.5. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Workflow
- 12.3.3. By Therapeutics Area
- 12.3.4. By Drug Type
- 12.3.5. By End User
- 12.4. Key Takeaways
- 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 13.2.1. By Country
- 13.2.1.1. India
- 13.2.1.2. Malaysia
- 13.2.1.3. Singapore
- 13.2.1.4. Thailand
- 13.2.1.5. Rest of South Asia
- 13.2.2. By Workflow
- 13.2.3. By Therapeutics Area
- 13.2.4. By Drug Type
- 13.2.5. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Workflow
- 13.3.3. By Therapeutics Area
- 13.3.4. By Drug Type
- 13.3.5. By End User
- 13.4. Key Takeaways
- 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 14.2.1. By Country
- 14.2.1.1. China
- 14.2.1.2. Japan
- 14.2.1.3. South Korea
- 14.2.2. By Workflow
- 14.2.3. By Therapeutics Area
- 14.2.4. By Drug Type
- 14.2.5. By End User
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Workflow
- 14.3.3. By Therapeutics Area
- 14.3.4. By Drug Type
- 14.3.5. By End User
- 14.4. Key Takeaways
- 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 15.2.1. By Country
- 15.2.1.1. Australia
- 15.2.1.2. New Zealand
- 15.2.2. By Workflow
- 15.2.3. By Therapeutics Area
- 15.2.4. By Drug Type
- 15.2.5. By End User
- 15.3. Market Attractiveness Analysis
- 15.3.1. By Country
- 15.3.2. By Workflow
- 15.3.3. By Therapeutics Area
- 15.3.4. By Drug Type
- 15.3.5. By End User
- 15.4. Key Takeaways
- 16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 16.2.1. By Country
- 16.2.1.1. GCC Countries
- 16.2.1.2. South Africa
- 16.2.1.3. Israel
- 16.2.1.4. Rest of MEA
- 16.2.2. By Workflow
- 16.2.3. By Therapeutics Area
- 16.2.4. By Drug Type
- 16.2.5. By End User
- 16.3. Market Attractiveness Analysis
- 16.3.1. By Country
- 16.3.2. By Workflow
- 16.3.3. By Therapeutics Area
- 16.3.4. By Drug Type
- 16.3.5. By End User
- 16.4. Key Takeaways
- 17. Key Countries Market Analysis
- 17.1. USA
- 17.1.1. Pricing Analysis
- 17.1.2. Market Share Analysis, 2022
- 17.1.2.1. By Workflow
- 17.1.2.2. By Therapeutics Area
- 17.1.2.3. By Drug Type
- 17.1.2.4. By End User
- 17.2. Canada
- 17.2.1. Pricing Analysis
- 17.2.2. Market Share Analysis, 2022
- 17.2.2.1. By Workflow
- 17.2.2.2. By Therapeutics Area
- 17.2.2.3. By Drug Type
- 17.2.2.4. By End User
- 17.3. Brazil
- 17.3.1. Pricing Analysis
- 17.3.2. Market Share Analysis, 2022
- 17.3.2.1. By Workflow
- 17.3.2.2. By Therapeutics Area
- 17.3.2.3. By Drug Type
- 17.3.2.4. By End User
- 17.4. Mexico
- 17.4.1. Pricing Analysis
- 17.4.2. Market Share Analysis, 2022
- 17.4.2.1. By Workflow
- 17.4.2.2. By Therapeutics Area
- 17.4.2.3. By Drug Type
- 17.4.2.4. By End User
- 17.5. Germany
- 17.5.1. Pricing Analysis
- 17.5.2. Market Share Analysis, 2022
- 17.5.2.1. By Workflow
- 17.5.2.2. By Therapeutics Area
- 17.5.2.3. By Drug Type
- 17.5.2.4. By End User
- 17.6. United kingdom
- 17.6.1. Pricing Analysis
- 17.6.2. Market Share Analysis, 2022
- 17.6.2.1. By Workflow
- 17.6.2.2. By Therapeutics Area
- 17.6.2.3. By Drug Type
- 17.6.2.4. By End User
- 17.7. France
- 17.7.1. Pricing Analysis
- 17.7.2. Market Share Analysis, 2022
- 17.7.2.1. By Workflow
- 17.7.2.2. By Therapeutics Area
- 17.7.2.3. By Drug Type
- 17.7.2.4. By End User
- 17.8. Spain
- 17.8.1. Pricing Analysis
- 17.8.2. Market Share Analysis, 2022
- 17.8.2.1. By Workflow
- 17.8.2.2. By Therapeutics Area
- 17.8.2.3. By Drug Type
- 17.8.2.4. By End User
- 17.9. Italy
- 17.9.1. Pricing Analysis
- 17.9.2. Market Share Analysis, 2022
- 17.9.2.1. By Workflow
- 17.9.2.2. By Therapeutics Area
- 17.9.2.3. By Drug Type
- 17.9.2.4. By End User
- 17.10. India
- 17.10.1. Pricing Analysis
- 17.10.2. Market Share Analysis, 2022
- 17.10.2.1. By Workflow
- 17.10.2.2. By Therapeutics Area
- 17.10.2.3. By Drug Type
- 17.10.2.4. By End User
- 17.11. Malaysia
- 17.11.1. Pricing Analysis
- 17.11.2. Market Share Analysis, 2022
- 17.11.2.1. By Workflow
- 17.11.2.2. By Therapeutics Area
- 17.11.2.3. By Drug Type
- 17.11.2.4. By End User
- 17.12. Singapore
- 17.12.1. Pricing Analysis
- 17.12.2. Market Share Analysis, 2022
- 17.12.2.1. By Workflow
- 17.12.2.2. By Therapeutics Area
- 17.12.2.3. By Drug Type
- 17.12.2.4. By End User
- 17.13. Thailand
- 17.13.1. Pricing Analysis
- 17.13.2. Market Share Analysis, 2022
- 17.13.2.1. By Workflow
- 17.13.2.2. By Therapeutics Area
- 17.13.2.3. By Drug Type
- 17.13.2.4. By End User
- 17.14. China
- 17.14.1. Pricing Analysis
- 17.14.2. Market Share Analysis, 2022
- 17.14.2.1. By Workflow
- 17.14.2.2. By Therapeutics Area
- 17.14.2.3. By Drug Type
- 17.14.2.4. By End User
- 17.15. Japan
- 17.15.1. Pricing Analysis
- 17.15.2. Market Share Analysis, 2022
- 17.15.2.1. By Workflow
- 17.15.2.2. By Therapeutics Area
- 17.15.2.3. By Drug Type
- 17.15.2.4. By End User
- 17.16. South Korea
- 17.16.1. Pricing Analysis
- 17.16.2. Market Share Analysis, 2022
- 17.16.2.1. By Workflow
- 17.16.2.2. By Therapeutics Area
- 17.16.2.3. By Drug Type
- 17.16.2.4. By End User
- 17.17. Australia
- 17.17.1. Pricing Analysis
- 17.17.2. Market Share Analysis, 2022
- 17.17.2.1. By Workflow
- 17.17.2.2. By Therapeutics Area
- 17.17.2.3. By Drug Type
- 17.17.2.4. By End User
- 17.18. New Zealand
- 17.18.1. Pricing Analysis
- 17.18.2. Market Share Analysis, 2022
- 17.18.2.1. By Workflow
- 17.18.2.2. By Therapeutics Area
- 17.18.2.3. By Drug Type
- 17.18.2.4. By End User
- 17.19. GCC Countries
- 17.19.1. Pricing Analysis
- 17.19.2. Market Share Analysis, 2022
- 17.19.2.1. By Workflow
- 17.19.2.2. By Therapeutics Area
- 17.19.2.3. By Drug Type
- 17.19.2.4. By End User
- 17.20. South Africa
- 17.20.1. Pricing Analysis
- 17.20.2. Market Share Analysis, 2022
- 17.20.2.1. By Workflow
- 17.20.2.2. By Therapeutics Area
- 17.20.2.3. By Drug Type
- 17.20.2.4. By End User
- 17.21. Israel
- 17.21.1. Pricing Analysis
- 17.21.2. Market Share Analysis, 2022
- 17.21.2.1. By Workflow
- 17.21.2.2. By Therapeutics Area
- 17.21.2.3. By Drug Type
- 17.21.2.4. By End User
- 18. Market Structure Analysis
- 18.1. Competition Dashboard
- 18.2. Competition Benchmarking
- 18.3. Market Share Analysis of Top Players
- 18.3.1. By Regional
- 18.3.2. By Workflow
- 18.3.3. By Therapeutics Area
- 18.3.4. By Drug Type
- 18.3.5. By End User
- 19. Competition Analysis
- 19.1. Competition Deep Dive
- 19.1.1. Albany Molecular Research Inc.
- 19.1.1.1. Overview
- 19.1.1.2. Product Portfolio
- 19.1.1.3. Profitability by Market Segments
- 19.1.1.4. Sales Footprint
- 19.1.1.5. Strategy Overview
- 19.1.1.5.1. Marketing Strategy
- 19.1.2. EVOTEC
- 19.1.2.1. Overview
- 19.1.2.2. Product Portfolio
- 19.1.2.3. Profitability by Market Segments
- 19.1.2.4. Sales Footprint
- 19.1.2.5. Strategy Overview
- 19.1.2.5.1. Marketing Strategy
- 19.1.3. Laboratory Corporation of America Holdings
- 19.1.3.1. Overview
- 19.1.3.2. Product Portfolio
- 19.1.3.3. Profitability by Market Segments
- 19.1.3.4. Sales Footprint
- 19.1.3.5. Strategy Overview
- 19.1.3.5.1. Marketing Strategy
- 19.1.4. GenScript
- 19.1.4.1. Overview
- 19.1.4.2. Product Portfolio
- 19.1.4.3. Profitability by Market Segments
- 19.1.4.4. Sales Footprint
- 19.1.4.5. Strategy Overview
- 19.1.4.5.1. Marketing Strategy
- 19.1.5. Pharmaceutical Product Development, LLC
- 19.1.5.1. Overview
- 19.1.5.2. Product Portfolio
- 19.1.5.3. Profitability by Market Segments
- 19.1.5.4. Sales Footprint
- 19.1.5.5. Strategy Overview
- 19.1.5.5.1. Marketing Strategy
- 19.1.6. Merck & Co., Inc.
- 19.1.6.1. Overview
- 19.1.6.2. Product Portfolio
- 19.1.6.3. Profitability by Market Segments
- 19.1.6.4. Sales Footprint
- 19.1.6.5. Strategy Overview
- 19.1.6.5.1. Marketing Strategy
- 19.1.7. Thermo Fisher Scientific Inc.
- 19.1.7.1. Overview
- 19.1.7.2. Product Portfolio
- 19.1.7.3. Profitability by Market Segments
- 19.1.7.4. Sales Footprint
- 19.1.7.5. Strategy Overview
- 19.1.7.5.1. Marketing Strategy
- 19.1.8. Dalton Pharma Services
- 19.1.8.1. Overview
- 19.1.8.2. Product Portfolio
- 19.1.8.3. Profitability by Market Segments
- 19.1.8.4. Sales Footprint
- 19.1.8.5. Strategy Overview
- 19.1.8.5.1. Marketing Strategy
- 19.1.9. Dr. Reddy Laboratories Ltd.
- 19.1.9.1. Overview
- 19.1.9.2. Product Portfolio
- 19.1.9.3. Profitability by Market Segments
- 19.1.9.4. Sales Footprint
- 19.1.9.5. Strategy Overview
- 19.1.9.5.1. Marketing Strategy
- 19.1.10. Pharmaron Beijing Co., Ltd.
- 19.1.10.1. Overview
- 19.1.10.2. Product Portfolio
- 19.1.10.3. Profitability by Market Segments
- 19.1.10.4. Sales Footprint
- 19.1.10.5. Strategy Overview
- 19.1.10.5.1. Marketing Strategy
- 19.1.11. TCG Lifesciences Pvt Ltd.
- 19.1.11.1. Overview
- 19.1.11.2. Product Portfolio
- 19.1.11.3. Profitability by Market Segments
- 19.1.11.4. Sales Footprint
- 19.1.11.5. Strategy Overview
- 19.1.11.5.1. Marketing Strategy
- 19.1.12. Domainex Ltd.
- 19.1.12.1. Overview
- 19.1.12.2. Product Portfolio
- 19.1.12.3. Profitability by Market Segments
- 19.1.12.4. Sales Footprint
- 19.1.12.5. Strategy Overview
- 19.1.12.5.1. Marketing Strategy
- 19.1.13. Eurofins SE
- 19.1.13.1. Overview
- 19.1.13.2. Product Portfolio
- 19.1.13.3. Profitability by Market Segments
- 19.1.13.4. Sales Footprint
- 19.1.13.5. Strategy Overview
- 19.1.13.5.1. Marketing Strategy
- 19.1.14. Syngene International Limited
- 19.1.14.1. Overview
- 19.1.14.2. Product Portfolio
- 19.1.14.3. Profitability by Market Segments
- 19.1.14.4. Sales Footprint
- 19.1.14.5. Strategy Overview
- 19.1.14.5.1. Marketing Strategy
- 20. Assumptions & Acronyms Used
- 21. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook